Lv41
648 积分 2024-06-28 加入
Early versus deferred use ofCDK4/6 inhibitors in advanced breast cancer
1个月前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
2个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
2个月前
已完结
Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis
3个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
3个月前
已完结
Low‐Dose Versus High‐Dose Lenvatinib in Radioiodine Refractory Differentiated Thyroid Cancer—A Real‐World Safety and Efficacy Analysis
4个月前
已完结
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer
4个月前
已关闭
卵巢恶性肿瘤患者诊治中的抗凝问题
4个月前
已完结
Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells
4个月前
已完结
Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
5个月前
已完结
BAT mitochondria: whitening meets softening
2个月前
已采纳
Tripeptide armour shields encapsulated proteins
2个月前
已采纳
Tripeptide armour shields encapsulated proteins
2个月前
已采纳
Tripeptide armour shields encapsulated proteins
2个月前
已采纳
Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
3个月前
已撤回
Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
3个月前
已采纳
Gastric precancerous process in a high risk population: cohort follow-up
3个月前
已采纳
皖公网安备34019202002308
